Analyst firms · Barclays · CTSH
Barclays CTSH price target and rating history
Cognizant Technology Solutions Corporation (CTSH) · Technology
Barclays rates Cognizant Technology Solutions Corporation (CTSH) Overweight with a $95 price target, as of its latest action on Dec 17, 2024. It has published 4 rating actions on CTSH since October 2021, including 2 upgrades and 0 downgrades. Across 4 firms with a CTSH price target in the last 12 months, the median target is $68.
- Current rating
- Overweight
- Price target
- $95
- Median target, all firms
- $68
- Actions on CTSH
- 4
Barclays price target on CTSH
Every Barclays rating on CTSH
- Dec 17, 2024
- Dec 14, 2023
- Feb 7, 2022
- Oct 29, 2021
How other firms rate CTSH
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Berenberg | Hold | $59 | Jun 17, 2026 |
| Wedbush | Outperform | $70 | Jun 8, 2026 |
| Truist Securities | Hold | $66 | Jun 1, 2026 |
| Deutsche Bank | Buy | $100 | Jan 26, 2026 |
| William Blair | Outperform | Nov 21, 2025 |
Questions about Barclays and CTSH
- What is Barclays's price target for CTSH?
- Barclays's latest stated price target for Cognizant Technology Solutions Corporation (CTSH) is $95, from its action on Dec 17, 2024.
- What is Barclays's rating on CTSH?
- Barclays rates CTSH Overweight, a bullish rating, as of Dec 17, 2024.
- When did Barclays last change its view on CTSH?
- On Dec 17, 2024, Barclays upgrades to Overweight from Equal Weight, price target $80 to $95.
- How does Barclays's CTSH target compare with other analysts?
- Across 4 firms with a CTSH price target in the last 12 months, the median target is $68.
More CTSH rating histories
- Deutsche Bank3
- Citigroup3
- Susquehanna3
- BofA Securities3
- Societe Generale3
- J.P. Morgan4
- HSBC3
- Morgan Stanley3
All Barclays ratingsCTSH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.